Screening, enrollment, and follow-up. A total of 20 patients were screened, and all 20 were enrolled. Of the 20 enrolled patients, 1 patient was not infused due to intercurrent lung adenocarcinoma and coincident finding of Richter transformation. Of the 19 patients who were infused, all had received ≥6 months of ibrutinib therapy before apheresis.